The Week in Review: February 9 – February 16, 2018

Friday, February 16, 2018 News Recap: HCV & Heart Disease: Evolving Recognition of Chronic Hepatitis C Infection as a Modifiable Risk Factor for CVD. This article examines the evidence for clinical and subclinical cardiovascular diseases in chronic hepatitis c infection, as well as the effect of treatment on cardiovascular outcomes. News from Around the World: NZ: Thousands of Hepatitis C sufferers unaware a cure is within reach. A Hepatitis...

Evolving Recognition of Chronic Hepatitis C Infection as a Modifiable Risk Factor for CVD

Many studies have identified extrahepatic manifestation of chronic hepatitis C virus (HCV) infection, including associations with lymphoproliferative disorders, diabetes mellitus, and renal disease. Increasingly, data have amassed exploring whether HCV infection acts as an independent risk factor for cardiovascular diseases. Evidence for Subclinical Cardiovascular Diseases in Chronic Hepatitis C Infection A recent review by Babiker et al published in the

Cardiovascular disease risk is higher for people with hepatitis C

People with hepatitis C are at higher risk of dying from cardiovascular disease suffering a stroke or developing cardiovascular problems than people with similar risk factors for heart disease who do not have hepatitis C, a meta-analysis of published studies has shown.The findings, published in the January 2016 edition of Gastroenterology, come from a meta-analysis of 22 epidemiological studies conducted by Salvatore Petta and colleagues at the University